Open AccessA RANDOMIZED PROSPECTIVE TRIAL OF ORAL ACYCLOVIR VS. ORAL GANCICLOVIR FOR CMV PROPHYLAXIS IN HIGH RISK KIDNEY TRANSPLANT RECIPIENTS
Author(s) -
Stuart M. Flechner,
Kiaran O’Malley,
R Fisher,
Barbara Mastroianni,
Doreen Papajcik,
Robin K. Avery,
Navdeep Boparai,
Charles S. Modlin,
David A. Goldfarb,
Andrew C. Novick
Publication year - 1998
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/00007890-199805131-00735
Subject(s) - medicine , ganciclovir , gastroenterology , serology , randomized controlled trial , kidney transplantation , aciclovir , transplantation , betaherpesvirinae , cytomegalovirus , surgery , human cytomegalovirus , herpesviridae , immunology , viral disease , antibody , virus